Galectin-9, a product of the LGALS9 gene, exerts a tumor-promoting activity in liver cancer, targeted by miR-22 [80], and a tumor-restraining activity in colon cancer [79] in which it is targeted by miR-455-5p. This evidence concerns the gene LGALS9 and colonic neoplasm.